{"id":"NCT02900352","sponsor":"Virginia Commonwealth University","briefTitle":"Zonisamide Treatment of Alcohol Use Disorder: an Evaluation of Efficacy and Mechanism of Action","officialTitle":"Zonisamide Treatment of Alcohol Use Disorder: an Evaluation of Efficacy and Mechanism of Action","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2016-10","primaryCompletion":"2021-04-22","completion":"2021-04-22","firstPosted":"2016-09-14","resultsPosted":"2022-10-13","lastUpdate":"2022-10-13"},"enrollment":156,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Alcohol Use Disorder"],"interventions":[{"type":"DRUG","name":"Zonisamide","otherNames":["Brand name: Zonegran"]},{"type":"DRUG","name":"Placebo","otherNames":["Brand name: Zonegran"]}],"arms":[{"label":"Zonisamide","type":"EXPERIMENTAL"},{"label":"Placebo","type":"PLACEBO_COMPARATOR"}],"summary":"This is a randomized, placebo-controlled, double-blind, 16 week trial of the medication zonisamide for the treatment of heavy drinking alcoholic civilians.","primaryOutcome":{"measure":"Number of Drinks Per Week","timeFrame":"over 8 weeks (weeks 9-16)","effectByArm":[{"arm":"Zonisamide","deltaMin":19.7,"sd":2.2},{"arm":"Placebo","deltaMin":23.7,"sd":1.98}],"pValues":[{"comp":"OG000 vs OG001","p":"0.0130"}]},"eligibility":{"minAge":"21 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":4,"exclusionCount":8},"locations":{"siteCount":4,"countries":["United States"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":2,"n":77},"commonTop":["Nasal Congestion/Runny Nose","Difficulty Sleeping","Back, Muscle, or Bone Pain","Fatigue","Extreme Tiredness"]}}